» Articles » PMID: 24587654

Role of Endoplasmic Reticulum Stress in the Pathogenesis of Nonalcoholic Fatty Liver Disease

Overview
Specialty Gastroenterology
Date 2014 Mar 4
PMID 24587654
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver disease (NAFLD) has emerged as a common public health problem in recent decades. However, the underlying mechanisms leading to the development of NAFLD are not fully understood. The endoplasmic reticulum (ER) stress response has recently been proposed to play a crucial role in both the development of steatosis and progression to nonalcoholic steatohepatitis. ER stress is activated to regulate protein synthesis and restore homeostatic equilibrium when the cell is stressed due to the accumulation of unfolded or misfolded proteins. However, delayed or insufficient responses to ER stress may turn physiological mechanisms into pathological consequences, including fat accumulation, insulin resistance, inflammation, and apoptosis, all of which play important roles in the pathogenesis of NAFLD. Therefore, understanding the role of ER stress in the pathogenesis of NAFLD has become a topic of intense investigation. This review highlights the recent findings linking ER stress signaling pathways to the pathogenesis of NAFLD.

Citing Articles

Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.

Biagioli M, Fiorucci S Liver Res. 2025; 5(3):119-141.

PMID: 39957845 PMC: 11791866. DOI: 10.1016/j.livres.2021.08.003.


Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue.

Park S, Cho Y, Son S, Hur J, Kim Y, Oh H Exp Mol Med. 2025; 57(2):466-477.

PMID: 39948368 PMC: 11873131. DOI: 10.1038/s12276-025-01403-6.


Antidiabetic Effects of Quercetin and Silk Sericin in Attenuating Dysregulation of Hepatic Gluconeogenesis in Diabetic Rats Through Potential Modulation of PI3K/Akt/FOXO1 Signaling: In Vivo and In Silico Studies.

Abdou H, Elmageed G, Hussein H, Yamari I, Chtita S, El-Samad L J Xenobiot. 2025; 15(1.

PMID: 39846548 PMC: 11755466. DOI: 10.3390/jox15010016.


Oligonucleotide therapies for nonalcoholic steatohepatitis.

Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J Mol Ther Nucleic Acids. 2024; 35(2):102184.

PMID: 38665220 PMC: 11044058. DOI: 10.1016/j.omtn.2024.102184.


Unraveling Adipose Tissue Dysfunction: Molecular Mechanisms, Novel Biomarkers, and Therapeutic Targets for Liver Fat Deposition.

Lopez-Yus M, Horndler C, Borlan S, Bernal-Monterde V, Arbones-Mainar J Cells. 2024; 13(5.

PMID: 38474344 PMC: 10931433. DOI: 10.3390/cells13050380.


References
1.
Targher G, Byrne C . Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab. 2013; 98(2):483-95. DOI: 10.1210/jc.2012-3093. View

2.
Tabas I, Ron D . Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol. 2011; 13(3):184-90. PMC: 3107571. DOI: 10.1038/ncb0311-184. View

3.
Hetz C, Bernasconi P, Fisher J, Lee A, Bassik M, Antonsson B . RETRACTED: Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science. 2006; 312(5773):572-6. DOI: 10.1126/science.1123480. View

4.
Wang S, Chen Z, Lam V, Han J, Hassler J, Finck B . IRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis. Cell Metab. 2012; 16(4):473-86. PMC: 3569089. DOI: 10.1016/j.cmet.2012.09.003. View

5.
Zeng L, Lu M, Mori K, Luo S, Lee A, Zhu Y . ATF6 modulates SREBP2-mediated lipogenesis. EMBO J. 2004; 23(4):950-8. PMC: 381012. DOI: 10.1038/sj.emboj.7600106. View